e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Jean-Luc Vachiéry, Marion Delcroix, Hikmet Al-Hiti, Michela Efficace, Martin Hutyra, Gabriela Lack, Kelly Papadakis, Lewis J. Rubin
Source:
Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Journal Issue:
February
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jean-Luc Vachiéry, Marion Delcroix, Hikmet Al-Hiti, Michela Efficace, Martin Hutyra, Gabriela Lack, Kelly Papadakis, Lewis J. Rubin. Macitentan in pulmonary hypertension due to left ventricular dysfunction. Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001
Left ventricular diastolic dysfunction in patients with pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
Left ventricular diastolic dysfunction in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 98s
Year: 2002
Right ventricular dysfunction in patients with pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019
Year: 2021
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 49 (6) 1601419; 10.1183/13993003.01419-2016
Year: 2017
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2008; 31: 1160-1166
Year: 2008
Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension
Source: Eur Respir J 2008; 31: 475-476
Year: 2008
Left ventricular systolic torsion is correlated to right ventricular dilation in pulmonary hypertension patients
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Right ventricular diastolic stiffness in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Right ventricular function and pulmonary haemodynamics
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018
More on the right ventricle in pulmonary hypertension
Source: Eur Respir J 2015; 45: 33-35
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept